Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $93.49 million. The enterprise value is $114.45 million.
| Market Cap | 93.49M |
| Enterprise Value | 114.45M |
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.48 million shares outstanding. The number of shares has increased by 330.61% in one year.
| Current Share Class | 3.48M |
| Shares Outstanding | 3.48M |
| Shares Change (YoY) | +330.61% |
| Shares Change (QoQ) | +4.98% |
| Owned by Insiders (%) | 7.82% |
| Owned by Institutions (%) | 28.04% |
| Float | 1.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.38 |
| Forward PS | 1.19 |
| PB Ratio | 2.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 1.51.
| Current Ratio | 2.79 |
| Quick Ratio | 1.75 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.16 |
Financial Efficiency
Return on equity (ROE) is -333.84% and return on invested capital (ROIC) is -61.76%.
| Return on Equity (ROE) | -333.84% |
| Return on Assets (ROA) | -36.45% |
| Return on Invested Capital (ROIC) | -61.76% |
| Return on Capital Employed (ROCE) | -35.44% |
| Weighted Average Cost of Capital (WACC) | 16.76% |
| Revenue Per Employee | $301,098 |
| Profits Per Employee | -$560,750 |
| Employee Count | 92 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +136.03% in the last 52 weeks. The beta is 3.20, so PTHS's price volatility has been higher than the market average.
| Beta (5Y) | 3.20 |
| 52-Week Price Change | +136.03% |
| 50-Day Moving Average | 24.75 |
| 200-Day Moving Average | 26.41 |
| Relative Strength Index (RSI) | 57.73 |
| Average Volume (20 Days) | 17,986 |
Short Selling Information
The latest short interest is 31,017, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 31,017 |
| Short Previous Month | 45,956 |
| Short % of Shares Out | 0.89% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, PTHS had revenue of $27.70 million and -$51.59 million in losses. Loss per share was -$20.19.
| Revenue | 27.70M |
| Gross Profit | 20.82M |
| Operating Income | -42.66M |
| Pretax Income | -58.98M |
| Net Income | -51.59M |
| EBITDA | n/a |
| EBIT | -42.66M |
| Loss Per Share | -$20.19 |
Balance Sheet
The company has $31.98 million in cash and $52.93 million in debt, with a net cash position of -$20.96 million or -$6.03 per share.
| Cash & Cash Equivalents | 31.98M |
| Total Debt | 52.93M |
| Net Cash | -20.96M |
| Net Cash Per Share | -$6.03 |
| Equity (Book Value) | 35.10M |
| Book Value Per Share | 10.42 |
| Working Capital | 44.80M |
Cash Flow
In the last 12 months, operating cash flow was -$35.08 million and capital expenditures -$293,000, giving a free cash flow of -$35.38 million.
| Operating Cash Flow | -35.08M |
| Capital Expenditures | -293,000 |
| Depreciation & Amortization | 1.34M |
| Net Borrowing | 45.02M |
| Free Cash Flow | -35.38M |
| FCF Per Share | -$10.18 |
Margins
Gross margin is 75.16%, with operating and profit margins of -154.01% and -186.24%.
| Gross Margin | 75.16% |
| Operating Margin | -154.01% |
| Pretax Margin | -212.90% |
| Profit Margin | -186.24% |
| EBITDA Margin | n/a |
| EBIT Margin | -154.01% |
| FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -330.61% |
| Shareholder Yield | -330.61% |
| Earnings Yield | -55.18% |
| FCF Yield | -37.84% |
Analyst Forecast
The average price target for PTHS is $57.71, which is 114.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $57.71 |
| Price Target Difference | 114.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 118.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PTHS has an Altman Z-Score of -0.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.83 |
| Piotroski F-Score | 2 |